chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Loss of personal independence in daily activities, Pain, Pain assessment
Clinical narrative: he has missed two days of work now; having abdominal pain; pain on palpation; This is a spontaneous report received from a contactable Nurse (Patient's mother). A 20 year old male patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot/Batch number not provided), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter wants to know if there is any compensation for people who have gotten the COVID-19 vaccine and experienced side effects. She states that he has missed two days of work now, he is a college student, and has a high insurance deductible. Her son got the vaccine on Friday and since Saturday he has been having abdominal pain, and pain on palpation. She wants to know if anyone else has reported these symptoms at this point. She states that she has reached out to her son's doctors. She states that she filled out a safety report online this morning. Caller states that she is trying to get a hold of his doctor by they have been busy. She states she is just going to take care of him now and see what today brings. Caller was given information: Side effects that have been reported with the Pfizer-BioNTech COVID-19 Vaccine include: injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, feeling unwell, swollen lymph nodes (lymphadenopathy), non-severe allergic reactions such as rash, itching, hives, or swelling of the face, severe allergic reactions, diarrhea, vomiting, arm pain. These may not be all the possible side effects of the Pfizer-BioNTech COVID-19 Vaccine. Serious and unexpected side effects may occur. Pfizer-BioNTech COVID-19 Vaccine is still being studied in clinical trials.1.The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Got bells palsy; This is a spontaneous report from a contactable consumer.  A 48-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; Batch/Lot Number: Ew0168), dose 2 via an unspecified route of administration, administered in left arm on 12Jun2021 14:30 PM (at the age of 48-year-old) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (Batch/Lot Number: Ewo182) via an unspecified route of administration, administered in left arm on 22May2021 14:30 PM as DOSE 2, SINGLE for covid-19 immunization. Not known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 02Jul2021 17:30 PM patient experienced got bells palsy. The adverse event result in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. The patient received treatment with steroids physical therapy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Event seriousness considered as disabling/incapacitating as per the reporter. The outcome of the event was not recovered.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bell's Palsy - right side; This is a spontaneous report from a contactable consumer (Patient). A 47-year-old male patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0151), dose 2 via an unspecified route of administration in the left arm on 13Apr2021 as dose 2, single for covid-19 immunisation. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration in the left arm on 23Mar2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not covid tested post vaccination. Patient was covid prior to vaccination. On 26Jul2021 at 21:00, the patient experienced bell's palsy - right side. Therapeutic measures were taken as a result of bell's palsy - right side. Patient received treatment of Antiviral and steroid. The outcome of the events was not recovered.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Inappropriate schedule of product administration, SARS-CoV-2 test
Clinical narrative: Inappropriate schedule; Tested  for COVID 27Jul2021; Tested  for COVID 27Jul2021; This is a spontaneous report from a contactable consumer. This 22-year-old male consumer (patient) reported for himself. A 22-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8732, Expiration date: unknown), via intramuscular, administered in left arm on 26Mar2021 (at the age of 22-year-old) as dose 1, single for COVID-19 immunization. Patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0162, Expiration date: unknown), via intramuscular, administered in left arm on 26Mar2021 (at the age of 22-year-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient was not diagnosed with covid-19 prior vaccination and tested for covid-19 after vaccination. On 27Jul2021, after the vaccination, the patient Tested  for COVID. Lab data includes PCR SARS-CoV-2 test on 26Jul2021 with unknown results and on 27Jul2021 which tested  for covid-19. The outcome of the events was recovering or resolving.  No follow-up attempts possible. No further information expected.  Follow-Up (30Jul2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nervousness, Tachycardia, Thyroiditis subacute
Clinical narrative: Thyroiditis subacute; lymphadenopathy; feeling shaky; tachycardic; This is a spontaneous report from a non-contactable consumer or other non health care professional. This case is crosslinked with cases MDEM21-02911 because they were generated from the same report. A 55-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced thyroiditis subacute, lymphadenopathy, feeling shaky and tachycardic, reported apyrexial. The side effects lasted 6 days. Time to onset was 6 days. Therapeutic measures were taken as a result of events, treated with Planned antibiotic therapy. No information about performed tests available. Outcome of all the events was not resolved.  The sender noted in their email: "As the case reports described in this signal have been transmitted from the National Centres to VigiBase, we kindly request you not to resubmit them to the correspondent Regulatory Authority as this is where they originate from." Product Complaint: There is no product complaint associated with this case.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Hormone level abnormal, Hyperthyroidism, Inflammation, Thyroid mass, Thyroiditis subacute
Clinical narrative: Hyperthyroidism after 2nd dose; Subacute thyroiditis after 2nd dose; Inflammation after 2nd dose; Nodules in the thyroid after 2nd dose; dysregulated thyroid hormones after 2nd dose; This is a spontaneous report from a non-contactable consumer. A 42-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown, Expiration date: Unknown), via unspecified route on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown, Expiration date: Unknown), via unspecified route on an unspecified date as dose 1, single for COVID-19 immunisation. On an unspecified date, the patient experienced subacute thyroiditis, hyperthyroidism and Inflammation. The patient underwent an Ultrasound thyroid that showed nodules in the thyroid with dysregulated thyroid hormones, hyperinflammation and Severe hyperthyroidism three weeks after second vaccination. The time to onset was 1 month. The patient was treated with prednisone for his Severe hyperthyroidism. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound thyroid
Clinical narrative: Hyperthyroidism after 2nd dose; Subacute thyroiditis after 2nd dose; Inflammation after 2nd dose; Nodules in the thyroid after 2nd dose; dysregulated thyroid hormones after 2nd dose; This is a spontaneous report from a non-contactable consumer. A 42-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown, Expiration date: Unknown), via unspecified route on an unspecified date as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown, Expiration date: Unknown), via unspecified route on an unspecified date as dose 1, single for COVID-19 immunisation. On an unspecified date, the patient experienced subacute thyroiditis, hyperthyroidism and Inflammation. The patient underwent an Ultrasound thyroid that showed nodules in the thyroid with dysregulated thyroid hormones, hyperinflammation and Severe hyperthyroidism three weeks after second vaccination. The time to onset was 1 month. The patient was treated with prednisone for his Severe hyperthyroidism. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Had symptomatic positive COVID test; Had symptomatic positive COVID test; This is a spontaneous report from a contactable consumer. An unspecified age and gender patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) via an unspecified route of administration on an unspecified date at dose number unknown, single for COVID-19 immunization. The medical history and concomitant medications were not reported. On an unspecified date the patients COVID test was positive. Prior vaccination within 4 weeks reported as none. It was reported that the patient was on vacation with 6 vaccinated adults all 3 was Pfizer vaccinated individuals and had symptomatic positive COVID test. Outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Had symptomatic positive COVID test; Had symptomatic positive COVID test; This is a spontaneous report from a contactable consumer. A contactable consumer reported similar events for 3 patients. This is one of 3 reports. A patient of unspecified age and gender received bnt162b2 (PFIZER/BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Prior vaccinations were none. Patient had symptomatic positive COVID on an unspecified date. The patient underwent lab tests and procedures which included Symptomatic positive covid test: positive on an unspecified date. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy
Clinical narrative: Bell's palsy; This is a spontaneous report from a contactable (patient). A 46-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection and lot number: FA7484) dose 1 via an unspecified route of administration, administered in arm right on 21Jul2021 (age at vaccination: 46-years-old) as dose 1, single for COVID Prevention/ COVID-19 immunisation. Medical history was none. There were no concomitant medications. On 21Jul2021, the patient was received the first dose of the vaccine. Two days later on 23Jul2021, he had a facial droop, his mouth got numb. The patient had some slurred speech. The patient went to the ER on 26Jul2021 (Monday). The patient did not get admitted to the hospital, it was just an ER visit. The patient was diagnosed with Bells Palsy and given steroid and another pill to take and left the hospital on Monday. The patient stated that it was still ongoing but it was stabilized right now because of the medications he was given by the hospital but his right eye won't close and he can't smile and he has pressure behind his right ear. The patient was just trying to figure out what happened because wednesday he was normal, and then he got the shot and two days later he went to the hospital. The patient does have more appointments coming up, but he was wondering what information Pfizer has on this side effect. The outcome for the event was not recovered.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: to get a test on Sun. July 25 to be sure; to get a test on Sun. July 25 to be sure; This is a spontaneous report from a contactable consumer or other non hcp.   A 35-years-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 07Apr2021 02:00 (at the age of 35-years-old) (Batch/Lot Number: Ew0153) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient started feeling sick in sat on 24Jul2021. Slight fever, body aches and congestion. Symptoms proceeded into the next day. Symptoms would fade and return. Went to Well Now Urgent Care to get a test on Sun. 25Jul2021 to be sure. The patient underwent lab test included nasal swab with positive result on 25Jul2021. No treatment in response to events was taken. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine, the patient was not diagnosed with COVID-19 prior to vaccination, the patient had been tested for COVID-19 since the vaccination with positive result. The outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lymphadenopathy, Pyrexia, Thyroiditis subacute
Clinical narrative: Thyroiditis subacute; Arthralgia; Headache; Lymphadenopathy; Pyrexia; This is a spontaneous report from a non-contactable consumer or other non hcp. This is 24 of 29 reports. A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported), dose 2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history included allergies to shellfish, mite and grasses from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch Number/Lot Number: Not reported) dose 1 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient experienced thyroiditis subacute, arthralgia, lymphadenopathy and pyrexia on an unspecified date. Serious criteria considered as medically significant, intervention required and the patient's hospitalization was prolonged as a result of thyroiditis subacute. The outcome of the events were reported as not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Had the 1st dose of the Pfizer Covid-19 vaccine last 19May and her son had Covid-19 virus last fall; Had the 1st dose of the Pfizer Covid-19 vaccine last 19May and her son had Covid-19 virus last fall; This is a spontaneous report from contactable consumer (patient's mother) via a Pfizer. A 19-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection) via an unspecified route of administration on 19May2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter reported that her son 19 y/o had the 1st dose of the Pfizer Covid-19 vaccine last May19 and her son had Covid-19 virus last fall in 2021. Reporter also stated her son refused to get the 2nd dose because the Pfizer Covid-19 vaccine is not agency approved and there were side effects such as Myocarditis which her son belongs to the age group with this side effect. Withheld would like to know about the 2nd dose window if it was given 3 or 6 weeks because some countries are delaying it until 12 weeks due to shortage. Withheld also would like to know if there was study for people who contracted the virus and had the 1st dose and if the 2nd dose was still needed in this case. Lab test included SARS-CoV-2 test as positive in 2021. The outcome of events was unknown.  Information about lot/batch number has been requested
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypertension
Clinical narrative: severe hypertension /his blood pressure was 190/125/very abnormal; This is a spontaneous report from a contactable consumer (father) received via Pfizer Sponsored Program and medical information team.  A 39-year-old male patient that received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: unknown), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: unknown), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The caller stated that, two or three weeks after the second dose of vaccine, the patient went to doctors office and his blood pressure was 190/125, which was very abnormal for the patient. The patient took medications for the event and was getting it under control. The caller had a question, if Pfizer was aware of any reports that may suggest this hypertension could have been caused by the Pfizer BioNTech Covid-19 Vaccine. The outcome of the event was recovering at the time of this report.  Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021294684 Same reporter/diff patient/diff event
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Caller states that 5 deaths, from that vaccine was reported; This is a spontaneous report from a contactable consumer reporting for a patient received from a Pfizer-sponsored program. This is the 2nd of 5 reports. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: unknown) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKOWN, SINGLE for Covid-19 immunization, age at vaccination unknown. The patients medical history and concomitant medications were not reported. Consumer stated that he did took a survey in his neighborhood, going door to door, and some people had taken the vaccine and some had not. Consumer stated that 5 deaths, from that vaccine was reported, and over 50% of people reported a debilitating disease, or cannot function, and have thousands of dollars in medical bills. The outcome of event was fatal. Autopsy was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100913512 Same reporter/drug/AE, different patient; Reported Cause(s) of Death: Consumer stated that 5 deaths, from that vaccine was reported
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: 5 deaths, from that vaccine was reported; This is a spontaneous report from a contactable consumer received from a Pfizer-sponsored program. This is the 3rd of 5 reports. A patient of an unspecified age and gender  received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: unknown) via an unspecified route of administration on an unspecified date as dose number unknown, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, Consumer stated that 5 deaths, from that vaccine was reported and over 50% of people reported a debilitating disease, or cannot function, and have thousands of dollars in medical bills. The outcome of event was fatal. Autopsy was unknown.  Information on the lot/ batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100913512 Same reporter/drug/AE, different patient; Reported Cause(s) of Death: 5 deaths, from that vaccine was reported
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Caller states that 5 deaths, from that vaccine was reported,; This is a spontaneous report from a contactable consumer received from a Pfizer-sponsored program. This consumer reported similar events for five patients. This is the 4th of five reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter called about the COVID 19 vaccine, Pfizer. The reporter did a survey in his neighborhood, going door to door, and some people had taken the vaccine and some had not. Reporter stated that 5 deaths from that vaccine was reported, and over 50% of people reported a debilitating disease, or cannot function, and have thousands of dollars in medical bills. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100913512 Same reporter/drug/AE, different patient; Reported Cause(s) of Death: Callers states that 5 deaths, from that vaccine was reported
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: deaths from that vaccine; This is a spontaneous report from a contactable consumer received from a Pfizer-sponsored program. This consumer reported similar events for five patients. This is the fifth of five reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter called about the COVID 19 vaccine, Pfizer. He did a survey in his neighborhood, going door to door, and some people had taken the vaccine and some had not. Reporter stated that 5 deaths from that vaccine was reported, and over 50% of people reported a debilitating disease, or cannot function, and have thousands of dollars in medical bills. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100913512 Same reporter/drug/AE, different patient; Reported Cause(s) of Death: deaths from that vaccine
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: died from the vaccine; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for 4 patients. This is one of four reports. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced died from the vaccine on an unspecified date. The reporter stated in his neighborhood 4 people died from the vaccine. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Follow-up attempts have been completed and no further information is expected. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100912595 same reporter, event and drug, different patient; Reported Cause(s) of Death: died from the vaccine
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: died from the vaccine; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for 4 patients. This is one of four reports. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced died from the vaccine on an unspecified date. The reporter stated in his neighborhood 4 people died from the vaccine. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Follow-up attempts have been completed and no further information is expected. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100912595 same reporter/drug/event, different pt; Reported Cause(s) of Death: died from the vaccine
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart Palpitations after first shot.; This is a spontaneous report from a contactable Professional (patient). A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: was not reported), via an unspecified route of administration on 31Dec2020 at the age of 40-years-old as dose 1, single dose for COVID-19 immunization. The patient's medical history included allergies. The patient's concomitant medications included unspecified medications received in two weeks of vaccination. Facility type vaccine was hospital. The patient did not receive other vaccine in four weeks of vaccination. Other vaccine same date vaccine date was 21Jan2021. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 02Jan2021 at 07:00, the patient experienced heart palpitations after first shot. The patient did not receive treatment for adverse event. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The outcome of event was not recovered.  Follow-up attempts completed. No further information expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Feeding disorder, Heart rate
Clinical narrative: my heart started racing going from 70- 120; dizzy; extremely weak; nauseous; diarrhea; unable to eat for 3 days; This is a spontaneous report from a contactable other hcp (Patient). A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EM 9810) via intramuscular route of administration (age at vaccination 36-year) in Right Arm on 03Feb2021 at 01:15 PM as dose 1, single for COVID-19 immunization. Medical history was reported none. There were no concomitant medications. No Known- allergies were reported. No COVID-prior-vaccination was reported. The patient was not tested COVID post-vaccination. The patient was not received other-vaccine-in-four weeks; no other medications was reported in-two weeks. On 05Feb2021 at 10:45 AM the patient experienced my heart started racing going from 70- 120, dizzy, extremely weak, nauseous, diarrhea, unable to eat for 3 days. AE-resulted-in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included heart rate: 70-120 (About 48hrs after taking the vaccine, my heart started racing going from 70-120) on an unspecified date. Therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events was recovering.  Follow-up (07MAY2021): Follow-up attempts completed. No further information expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Palpitations
Clinical narrative: my heart started racing going from 70- 120; dizzy; extremely weak; nauseous; diarrhea; unable to eat for 3 days; This is a spontaneous report from a contactable other hcp (Patient). A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EM 9810) via intramuscular route of administration (age at vaccination 36-year) in Right Arm on 03Feb2021 at 01:15 PM as dose 1, single for COVID-19 immunization. Medical history was reported none. There were no concomitant medications. No Known- allergies were reported. No COVID-prior-vaccination was reported. The patient was not tested COVID post-vaccination. The patient was not received other-vaccine-in-four weeks; no other medications was reported in-two weeks. On 05Feb2021 at 10:45 AM the patient experienced my heart started racing going from 70- 120, dizzy, extremely weak, nauseous, diarrhea, unable to eat for 3 days. AE-resulted-in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included heart rate: 70-120 (About 48hrs after taking the vaccine, my heart started racing going from 70-120) on an unspecified date. Therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events was recovering.  Follow-up (07MAY2021): Follow-up attempts completed. No further information expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Palpitations
Clinical narrative: dizziness; heart palpitations; This is a spontaneous report from a contactable consumer or other non hcp. This consumer (patient) reported for herself that a 57-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9269), dose 2 via an unspecified route of administration, administered in Arm Left on 09Feb2021 10:30 (Age at vaccination 57 years) as dose 2, single for covid-19 immunisation. Medical history included rheumatoid arthritis from 2009 and ongoing, blood pressure high from 2000 and ongoing and stress from an unknown date and unknown if ongoing (She said her high blood pressure was brought on by stress). There were no concomitant medications. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number : EL3249, Expiration date: Unknown), via an intramuscular route of administration on 20Jan2021 (Age at vaccination 57 years) as dose 1, single for covid-19 immunisation. On 13Feb2021, the patient experienced heart palpitations; On 28Feb2021, dizziness. The patient was not received treatment for events. Patient did not performed lab test. It was reported that caller stated she received both doses of Pfizer COVID 19 vaccines. The first dose was on 20Jan2021 which she had no side effects. The second dose on 9Feb2021. That weekend on 13Feb2021 and for 2 weeks on she experienced heart palpitations and dizziness started on 28Feb2021. She stated it's been the same. She went back and looked at the information and knows they are side effects but she wants to know how long should they last. She stated the hospital is the last place I want to go. The dizziness, it ok. It's the heart palpitations are more bothersome. Consumer stated, "I was wondering, because I got my first Pfizer dose on 20Jan (not clarified) and then I got my second dose on 09Feb (not clarified) and from about two weeks, I have been having heart palpitation and yesterday, I started getting little dizzy. So, I looked at the publish sheet that they gave me and those two were the side effects. She said both the heart palpitations and dizziness have persisted. Additional Information for Other Conditions: Reported she was diagnosed with high blood pressure in approximately 2000. She said her high blood pressure was brought on by stress. She said she was able to get off her medication at one point, but then her husband got sick and the stress from that caused her to start taking medication again. She said she did not want to go to the hospital because of the COVID-19 Virus. Vaccination facility type was hospital. No additional vaccine administered on Same Date of the Pfizer Suspect. Patient did not visited to emergency room and physician office. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The clinical outcome of both events were not recovered.   Investigation Assessment: No  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Blood pressure decreased, Blood pressure increased, Blood pressure measurement, Body temperature
Clinical narrative: Heart palpitations; Tachycardia; shortness of breath; numbness in arms and body more on left side; eyelids very tired and droopy; chest pain; nausea; vomiting; diarrhoea; abdominal pain; cold sweats; drastic body temperature change; bottom lip swelling; headaches; lightheaded; cold hands and cold feet; flushing warmth in face; tingling sensation in hands and feet; increased blood pressure; Blood pressure decreased; foggy brain; memory lapses; blurry vision; This is a spontaneous report from a contactable other healthcare professional. A 28-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29Jan2021 17:45 (at the age of 28-years-old) (Batch/Lot Number: EL9262) as dose 2, single for covid-19 immunisation. The patient medical history was reported as none. Concomitant medications included docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3), multivitamin, vitamin d3 and vitamin c (ascorbic acid). Start and stop dates of all concomitant medications were not reported. There were no known allergies. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Jan2021 17:45 (Batch/Lot Number: EL1283) for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. On 29Jan2021 19:30, the patient experienced heart palpitations, tachycardia, shortness of breath, numbness in arms and body more on left side, eyelids very tired and droopy, chest pain, nausea, vomiting, diarrhoea, abdominal pain, cold sweats, drastic body temperature change, bottom lip swelling, headaches, lightheaded, cold hands and cold feet, flushing warmth in face, tingling sensation in hands and feet, increased blood pressure, blood pressure decreased, foggy brain, memory lapses and blurry vision. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Laboratory tests on an unspecified date included: blood pressure was increased, blood pressure was decreased, body temperature showed drastic body temperature change and on 20Feb2021 sars-cov-1 test was negative (nasal swab). The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature fluctuation, Chest pain, Chills, Diarrhoea, Dizziness
Clinical narrative: Heart palpitations; Tachycardia; shortness of breath; numbness in arms and body more on left side; eyelids very tired and droopy; chest pain; nausea; vomiting; diarrhoea; abdominal pain; cold sweats; drastic body temperature change; bottom lip swelling; headaches; lightheaded; cold hands and cold feet; flushing warmth in face; tingling sensation in hands and feet; increased blood pressure; Blood pressure decreased; foggy brain; memory lapses; blurry vision; This is a spontaneous report from a contactable other healthcare professional. A 28-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29Jan2021 17:45 (at the age of 28-years-old) (Batch/Lot Number: EL9262) as dose 2, single for covid-19 immunisation. The patient medical history was reported as none. Concomitant medications included docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3), multivitamin, vitamin d3 and vitamin c (ascorbic acid). Start and stop dates of all concomitant medications were not reported. There were no known allergies. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Jan2021 17:45 (Batch/Lot Number: EL1283) for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. On 29Jan2021 19:30, the patient experienced heart palpitations, tachycardia, shortness of breath, numbness in arms and body more on left side, eyelids very tired and droopy, chest pain, nausea, vomiting, diarrhoea, abdominal pain, cold sweats, drastic body temperature change, bottom lip swelling, headaches, lightheaded, cold hands and cold feet, flushing warmth in face, tingling sensation in hands and feet, increased blood pressure, blood pressure decreased, foggy brain, memory lapses and blurry vision. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Laboratory tests on an unspecified date included: blood pressure was increased, blood pressure was decreased, body temperature showed drastic body temperature change and on 20Feb2021 sars-cov-1 test was negative (nasal swab). The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Eyelid ptosis, Feeling abnormal, Flushing, Headache
Clinical narrative: Heart palpitations; Tachycardia; shortness of breath; numbness in arms and body more on left side; eyelids very tired and droopy; chest pain; nausea; vomiting; diarrhoea; abdominal pain; cold sweats; drastic body temperature change; bottom lip swelling; headaches; lightheaded; cold hands and cold feet; flushing warmth in face; tingling sensation in hands and feet; increased blood pressure; Blood pressure decreased; foggy brain; memory lapses; blurry vision; This is a spontaneous report from a contactable other healthcare professional. A 28-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29Jan2021 17:45 (at the age of 28-years-old) (Batch/Lot Number: EL9262) as dose 2, single for covid-19 immunisation. The patient medical history was reported as none. Concomitant medications included docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3), multivitamin, vitamin d3 and vitamin c (ascorbic acid). Start and stop dates of all concomitant medications were not reported. There were no known allergies. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Jan2021 17:45 (Batch/Lot Number: EL1283) for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. On 29Jan2021 19:30, the patient experienced heart palpitations, tachycardia, shortness of breath, numbness in arms and body more on left side, eyelids very tired and droopy, chest pain, nausea, vomiting, diarrhoea, abdominal pain, cold sweats, drastic body temperature change, bottom lip swelling, headaches, lightheaded, cold hands and cold feet, flushing warmth in face, tingling sensation in hands and feet, increased blood pressure, blood pressure decreased, foggy brain, memory lapses and blurry vision. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Laboratory tests on an unspecified date included: blood pressure was increased, blood pressure was decreased, body temperature showed drastic body temperature change and on 20Feb2021 sars-cov-1 test was negative (nasal swab). The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lip swelling, Memory impairment, Nausea, Palpitations
Clinical narrative: Heart palpitations; Tachycardia; shortness of breath; numbness in arms and body more on left side; eyelids very tired and droopy; chest pain; nausea; vomiting; diarrhoea; abdominal pain; cold sweats; drastic body temperature change; bottom lip swelling; headaches; lightheaded; cold hands and cold feet; flushing warmth in face; tingling sensation in hands and feet; increased blood pressure; Blood pressure decreased; foggy brain; memory lapses; blurry vision; This is a spontaneous report from a contactable other healthcare professional. A 28-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29Jan2021 17:45 (at the age of 28-years-old) (Batch/Lot Number: EL9262) as dose 2, single for covid-19 immunisation. The patient medical history was reported as none. Concomitant medications included docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3), multivitamin, vitamin d3 and vitamin c (ascorbic acid). Start and stop dates of all concomitant medications were not reported. There were no known allergies. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Jan2021 17:45 (Batch/Lot Number: EL1283) for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. On 29Jan2021 19:30, the patient experienced heart palpitations, tachycardia, shortness of breath, numbness in arms and body more on left side, eyelids very tired and droopy, chest pain, nausea, vomiting, diarrhoea, abdominal pain, cold sweats, drastic body temperature change, bottom lip swelling, headaches, lightheaded, cold hands and cold feet, flushing warmth in face, tingling sensation in hands and feet, increased blood pressure, blood pressure decreased, foggy brain, memory lapses and blurry vision. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Laboratory tests on an unspecified date included: blood pressure was increased, blood pressure was decreased, body temperature showed drastic body temperature change and on 20Feb2021 sars-cov-1 test was negative (nasal swab). The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral coldness, SARS-CoV-1 test, Tachycardia, Vision blurred
Clinical narrative: Heart palpitations; Tachycardia; shortness of breath; numbness in arms and body more on left side; eyelids very tired and droopy; chest pain; nausea; vomiting; diarrhoea; abdominal pain; cold sweats; drastic body temperature change; bottom lip swelling; headaches; lightheaded; cold hands and cold feet; flushing warmth in face; tingling sensation in hands and feet; increased blood pressure; Blood pressure decreased; foggy brain; memory lapses; blurry vision; This is a spontaneous report from a contactable other healthcare professional. A 28-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 2 via an unspecified route of administration, administered in Arm Left on 29Jan2021 17:45 (at the age of 28-years-old) (Batch/Lot Number: EL9262) as dose 2, single for covid-19 immunisation. The patient medical history was reported as none. Concomitant medications included docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3), multivitamin, vitamin d3 and vitamin c (ascorbic acid). Start and stop dates of all concomitant medications were not reported. There were no known allergies. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08Jan2021 17:45 (Batch/Lot Number: EL1283) for covid-19 immunisation. The patient did not receive any other vaccine within 4 weeks of covid-19 vaccine. On 29Jan2021 19:30, the patient experienced heart palpitations, tachycardia, shortness of breath, numbness in arms and body more on left side, eyelids very tired and droopy, chest pain, nausea, vomiting, diarrhoea, abdominal pain, cold sweats, drastic body temperature change, bottom lip swelling, headaches, lightheaded, cold hands and cold feet, flushing warmth in face, tingling sensation in hands and feet, increased blood pressure, blood pressure decreased, foggy brain, memory lapses and blurry vision. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Laboratory tests on an unspecified date included: blood pressure was increased, blood pressure was decreased, body temperature showed drastic body temperature change and on 20Feb2021 sars-cov-1 test was negative (nasal swab). The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.